Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

British American Tobacco p.l.c. (BTI)

As of 2026-11-18 · 11/15 boxes filled from SEC filings and market data

Report price $59.16 (close 2026-11-17); latest close $56.84 (2026-11-20), -3.9% since the report; figures re-marked at the latest close

Conclusion: PASS

Conviction low · base case none · downside -20% · upside +11%

At $59.16 the market capitalises BTI at $136.80B, paying 15.8x FY2025 tax-normalized operating earnings and 13.3x FY2025 GAAP net income against guidance for 3-5% constant-FX revenue growth and adjusted EPS growth toward the middle of 5-8%. The reverse DCF requires -4.6% revenue a year for ten years, below the -1.0% delivered in FY2025 and the guided growth, so the market is pricing decay rather than the base business. Even so, the asymmetry is not enough to act: there is no base case, because no comparable peer multiple sets one and a base at today's multiple is today's price by construction. The downside case is $45.26, -23.5%, from a -10.0% earnings case at a compressed P/E of 13.43x (today 15.8x). The upside case is $63.01, +6.5%, from +6.5% earnings at today's P/E of 15.8x. With the call resting on those two cases alone, the reward does not cover the downside, so the call is PASS with low conviction.

Key numbers

  • Share price: $56.84
  • Market cap: $131.44B
  • Latest financial period: FY Dec 2025 to Dec 31, 2025
  • Revenue (FY Dec 2025): £25.61B
  • P/E (FY Dec 2025): 12.8x
  • FCF yield: 5.8%
  • Price / book: 2.16x
  • P/E, operating (tax-normalized) (FY Dec 2025): 15.2x
  • EV / FCF (FY Dec 2025): 22.6x
  • Revenue growth (latest fiscal year): -1.0%
  • ROIC (FY Dec 2025): 10.1%
  • WACC: 5.2%
  • Economic profit spread: +4.9 pts

The 15 boxes

  1. ✓ 1. Long-form business notes

    BAT is a £25.6bn-revenue (FY2025) multi-category nicotine group, still overwhelmingly combustible: cigarettes and other combustibles were £20,201m, or 78.9% of FY2025 revenue, against £3,621m (14.1%) from New Categories (Vapour, Heated Products, Modern Oral) and £1,043m (4.1%) Traditional Oral. It sells in over 140 markets for combustibles, run through three regions where the U.S. alone was £11,534m of FY2025 revenue, and manufactures through 36 fully integrated cigarette facilities in 35 markets. Between FY2020 and FY2025 revenue was broadly flat (£25.78B to £25.61B) while FY2025 operating income was £10.00B but operating cash flow fell to £6.34B from £10.12B; the mix is shifting via Modern Oral (+47.4% to £1,165m in FY2025) even as Vapour fell 10.4% to £1,542m. The newest figures here are FY2025 (year ended 31 December 2025, 20-F dated 2026-02-13); FY2026 gross capex guidance is around £750 million.

  2. ✓ 2. Competitive advantage

    British American Tobacco has the accounting signature of a durable franchise rather than a commodity: FY2025 revenue of £25.61B produced £10.00B of operating income (about 39%), revenue has sat inside a narrow £25.61B–£27.66B band in every year FY2020–FY2025, and capex of £460M–£551M a year is dwarfed by operating cash flow of £6.34B–£10.71B. What the sources support is scale plus brand ownership, not a named competitive position — no competitor, market share or volume/price-mix data appears in them. The blemish is reported-earnings volatility: an FY2023 operating loss of £15.75B and FY2024 net income exceeding operating income mean only the normal-run years (FY2020–FY2022, FY2025) can carry margin and return conclusions. US litigation and settlement structures are a standing contingent claim that the Group does not provide for.

  3. ✓ 3. 10-Q takeaways

    Latest interim release (H1 2026, six months to 30 June 2026): revenue £12,235m, +1.4% reported/+2.9% constant; adjusted profit from operations up 2.5% to £5,530m at constant, and as adjusted for Canada up 3.5% to £5,421m with adjusted operating margin 43.7%, +30 bps. Reported operating margin fell to 34.9% on £1,160m of adjusting items. Cash conversion was 79.7%, the £1.3bn 2026 buyback is on track, and FY26 guidance is confirmed with 3-5% revenue growth, mid-teens New Categories growth and adjusted diluted EPS growth toward the middle of 5-8%.

  4. ✓ 4. Corporate governance

    Filled; members read this box.

  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ○ 9. Insider trading interpretation
  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans